Building Resilience Against Covid-19 Pandemic Using Artificial Intelligence, Machine Learning, and Iot: A Survey of Recent Progress
Building Resilience Against Covid-19 Pandemic Using Artificial Intelligence, Machine Learning, and Iot: A Survey of Recent Progress
Building Resilience Against Covid-19 Pandemic Using Artificial Intelligence, Machine Learning, and Iot: A Survey of Recent Progress
Review
Building Resilience against COVID-19 Pandemic
Using Artificial Intelligence, Machine Learning,
and IoT: A Survey of Recent Progress
S. M. Abu Adnan Abir 1 , Shama Naz Islam 2 , Adnan Anwar 3 , Abdun Naser Mahmood 4, *
and Aman Maung Than Oo 2
1 IGW Operators Forum, Dhaka 1212, Bangladesh; adnanabir.iut@gmail.com
2 School of Engineering, Deakin University, Geelong, VIC 3216, Australia; shama.i@deakin.edu.au (S.N.I.);
aman.m@deakin.edu.au (A.M.T.O.)
3 Strategic Centre for Cyber Security Research & Innovation (CSRI), School of Information Technology,
Deakin University, Geelong, VIC 3216, Australia; adnan.anwar@deakin.edu.au
4 School of Engineering and Mathematical Sciences, La Trobe University, Melbourne, VIC 3086, Australia
* Correspondence: A.Mahmood@latrobe.edu.au; Tel.: +61-3-9479-2145
Received: 6 November 2020; Accepted: 4 December 2020; Published: 6 December 2020
Abstract: Coronavirus disease 2019 (COVID-19) has significantly impacted the entire world today and
stalled off regular human activities in such an unprecedented way that it will have an unforgettable
footprint on the history of mankind. Different countries have adopted numerous measures to build
resilience against this life-threatening disease. However, the highly contagious nature of this pandemic
has challenged the traditional healthcare and treatment practices. Thus, artificial intelligence (AI)
and machine learning (ML) open up new mechanisms for effective healthcare during this pandemic.
AI and ML can be useful for medicine development, designing efficient diagnosis strategies and
producing predictions of the disease spread. These applications are highly dependent on real-time
monitoring of the patients and effective coordination of the information, where the Internet of
Things (IoT) plays a key role. IoT can also help with applications such as automated drug delivery,
responding to patient queries, and tracking the causes of disease spread. This paper represents a
comprehensive analysis of the potential AI, ML, and IoT technologies for defending against the
COVID-19 pandemic. The existing and potential applications of AI, ML, and IoT, along with a
detailed analysis of the enabling tools and techniques are outlined. A critical discussion on the risks
and limitations of the aforementioned technologies are also included.
1. Introduction
Humanity is now encountering a global crisis, perhaps the greatest crisis of this generation:
The COVID-19 pandemic. People all over the world came to know this disease first on 31 December 2019,
when the Wuhan Municipal Health Commission, China, reported a cluster of cases of pneumonia in
Wuhan, Hubei Province which was ultimately identified as a novel virus named SARS-COV-2 resulting
in the disease named “coronavirus disease 2019”, also known as COVID-19. On 13 January 2020,
officials confirmed the first recorded COVID-19 case outside of China. After the disease started
spreading all over the world, the World Health Organization (WHO) categorized this epidemic as a
pandemic on 11 March 2020 [1]. As of 24 August 2020, COVID-19 has spread over 213 countries and
territories around the world, resulting in over 23,586,023 reported cases of confirmed contamination
and 812,527 deaths [2,3]. Figure 1 illustrates COVID-19 spreading over time, which is very alarming
as the rate of the new victims is rising at a significantly higher rate. Some of the countries, such as
confirmed contamination and 812,527 deaths [2,3]. Figure 1 illustrates COVID-19 spreading over time,
which is very alarming as the rate of the new victims is rising at a significantly higher rate. Some of
Australia, that experienced a decreasing number due to social distancing, are also facing a second
the countries, such as Australia, that experienced a decreasing number due to social distancing, are
wave of the COVID-19 pandemic.
also facing a second wave of the COVID-19 pandemic.
25 900
800
20
700
Cumulative Confirmed Case
600
Thousands
500
400
10
300
200
5
100
- -
week-0
week-2
week-4
week-6
week-8
week-10
week-12
week-14
week-16
week-18
week-20
week-22
week-24
week-26
week-28
week-30
week-32
Time duration
Figure 1. The statistics of the coronavirus disease 2019 (COVID-19) disease outbreak over the world,
Figure 1. The statistics of the coronavirus disease 2019 (COVID-19) disease outbreak over the world,
the figure shows (a) the accumulative figure of confirmed infected cases and (b) the accumulative
the figure shows (a) the accumulative figure of confirmed infected cases and (b) the accumulative figure
figure of deaths.
of deaths.
The healthcare sector has put a great effort into COVID-19 diagnosis, screening and treating the
The healthcare sector has put a great effort into COVID-19 diagnosis, screening and treating
infected individuals to address this pandemic. Governments and international organizations are
the infected individuals to address this pandemic. Governments and international organizations are
aiming to organize an appropriate level of healthcare to mitigate the disease. To date, no medicine or
aiming to organize an appropriate level of healthcare to mitigate the disease. To date, no medicine or
vaccine has been invented to encounter this disease with complete assurance. So, different treatment
vaccine has been invented to encounter this disease with complete assurance. So, different treatment
methods and different medicines are applied as appropriate to remedy against this disease. On the
methods and different
other hand, authorities medicines
are imposingare applied
measures assuch
appropriate
as social to remedy against
distancing, this disease.
area lockdown, the useOnofthe
other hand,
proper authorities
sanitization, are
etc. toimposing
prevent the measures such as social
further spreading of thisdistancing, area lockdown,
pandemic. Therefore, to preventthe use
the of
spreading of this disease, a collective effort is needed from all social entities such as the internationalthe
proper sanitization, etc. to prevent the further spreading of this pandemic. Therefore, to prevent
organizations,
spreading governments,
of this disease, healthcare
a collective systems,
effort is neededandfrommore essentially
all social entities from
such as thethecommunity.
international
Moreover, the
organizations, widespread
governments, integration
healthcare of prospective
systems, technologies
and more essentially fromwith effective healthcare
the community. Moreover,
themanagement
widespreadand resilient governance
integration of prospectivewill technologies
reinforce the capacity to protect
with effective the society
healthcare from COVID-and
management
19 disease
resilient [4].
governance will reinforce the capacity to protect the society from COVID-19 disease [4].
With
With thethe emergence
emergence ofofintelligent
intelligenttechnologies
technologies in in this
thisage
ageofofinformation
information from
fromthethe
global
globalcontext,
context,
advanced
advanced artificial
artificial intelligence(AI)
intelligence (AI)techniques
techniques promise
promisemassive
massiveapplications
applications in in
a variety
a variety of sectors.
of sectors.
Figure
Figure 2 exhibits
2 exhibits artificialintelligence
artificial intelligenceandand its
its subsections,
subsections, especially
especiallyfromfroma amachine
machine learning
learning(ML)
(ML)
point of view [4]. Although social distancing and the use of masks/gloves have been
point of view [4]. Although social distancing and the use of masks/gloves have been proven effective to proven effective
to slow down the spread, effective countermeasures and defense strategies need to be developed to
slow down the spread, effective countermeasures and defense strategies need to be developed to build
build resilience against the pandemic through better monitoring and control. AI and ML, which have
resilience against the pandemic through better monitoring and control. AI and ML, which have been
been successfully applied in a wide range of research areas, may have numerous prospective
successfully applied in a wide range of research areas, may have numerous prospective applications
applications for achieving protection from COVID-19 disease. AI and ML can play a significant role
for achieving protection from COVID-19 disease. AI and ML can play a significant role in addressing
in addressing the healthcare and social sector challenges caused by the COVID-19 pandemic. On a
the healthcare and social sector challenges caused by the COVID-19 pandemic. On a molecular level,
AI can be utilized to approximate the construction of SARS-COV-2 associated proteins, classify present
medications that can possibly be used as a remedy for the disease, suggest novel composites that
IoT 2020, 1 508
Figure 2. The relation between artificial intelligence and its components [10].
IoT 2020, 1 509
From the above discussion, we can summarize that organizations and researchers across different
countries are putting their best effort to build resilience against this pandemic. As AI, ML, and IoT have
been proven effective in a wide range of application areas, this paper concentrates on evaluating the
scope of these emerging technologies and recent progress in developing the countermeasures against
COVID-19 pandemic. Specifically, this paper addresses the following key research questions:
i. What are the emerging applications of AI and ML that can help toward building resilience
against the COVID-19 pandemic? The answer of this question has been explored in Section 2.
ii. What are the social and information science-related applications of AI and ML that played an
important role during this crisis? The answer of this question has been elaborated in Section 3.
iii. What are the roles of emerging technologies such as IoT for COVID-19 control and prevention?
The answer of this question has been identified in Section 4.
iv. Is there any potential risk due to the integration of emerging intelligent techniques such as AI,
ML, and IoT? The answer to this question has been explored in Section 5.
by infectious disease scientists to research innovative solutions for mitigating the initial SARS
outbreak, designed the first risk-based solution for detecting the outbreak of SARS-COV-2 virus [11].
This successful demonstration of AI and ML in predicting disease outbreaks applied BlueDot’s prior
research on the SARS outbreak to implement advanced technologies. A report stated that BlueDot
employed a disease-monitoring framework that scrutinized over 100,000 online documents globally
in 65 languages every 15 min [4]. This system identified unusual statistics of pneumonia cases
with unidentified cause in Wuhan, the ninth most populated city in China, and it warned about the
occurrence of the disease considerably earlier than when it was formally recognized as COVID-19 [4].
Therefore, these advanced technologies can forecast such epidemics and create awareness among
people to take the required pre-cautions for encountering the outbreaks.
Artificial intelligence application in detecting infectious diseases is extremely valuable in the
medical sector and can bring revolutions to the healthcare practices. Integrating AI in the imaging
processes has received significant attention within the healthcare sector. Machine-learning prototypes
can scrutinize the medical images to identify the sickness at an initial phase. Such prototypes are
driven by big data and deep learning algorithms to achieve the particular task. The prospective
sectors where this image-oriented learning is possibly applied are pathology, ophthalmology, radiology,
and dermatology [4]. The mitigation of diseases such as COVID-19 massively depends on the screening
of people through pathogenic testing, which is a time-consuming process, and hence, precision is
a must. In a study, the author introduced a medical identification process for COVID-19 based on
radiographic variations in computerized tomography (CT) scans by implementing the deep learning
process, which achieve 85.2% accuracy in the testing and validation stage. [4].
Machine learning can assist the work of medical professionals by analyzing and organizing an
enormous amount of patient information stored in digital medical records. Moreover, Machine Learning
is applied in different medical applications that include detecting patients with severe conditions
who urgently require intensive care unit (ICU) facilities, identifying early symptoms of diseases,
understanding the breathing condition of the patient by analyzing chest X-rays, etc. Therefore,
AI and ML improves the performance of identification and prediction process and how administrative
decisions are made in the medical sector [4]. In these circumstances of the COVID-19 pandemic,
the aforementioned technologies have already aided medical professionals encountering the situations
in a significantly effective manner.
against the COVID-19 pandemic. The success of the AI-enabled tools are not only limited as a prototype
these days, as a good number of commercial applications have also been introduced. Those applications
incorporate the strengths of powerful deep learning and intelligent techniques to help slow down the
spread and improved identification of the virus and thus exhibit technological competence against the
spread of the pandemic [12].
In [14], the authors describe a process where deep transfer learning was used with Generative
Adversarial Network (GAN) for COVID-19 recognition in X-ray images of a patient’s chest.
Ian Goodfellow introduced the Generative Adversarial Network (GAN) in 2014, which is a type of
deep learning algorithm. GAN prototypes are mainly comprised of two networks, generative and
discriminative network. The generator network is designed to generate new fake data instances,
which are similar to training data. The purpose of the discriminator is to differentiate between actual
data and fake data generated from a generator network. The generator network produces fake data to
evade the network, and the discriminator network identifies the difference between actual and fake
data and tries to prevent the evasion, which is the mission of the GAN models. The shortage of records
regarding COVID-19 such as chest X-rays images is the key motivation for considering this type of
model in [14]. The main idea of this GAN-based study is to gather all the available imaging data
and COVID-19 test results and then utilize the GAN network to create more datasets to assist in the
identification of the virus from the available X-rays scans with the maximum accuracy.
Another study [15] presents an early detection of COVID-19 using machine learning techniques,
where the detection procedure was employed on CT scans of an abdomen. The experienced radiologists
identified from CT scans that COVID-19 indicates dissimilar characteristics as compared to other viral
pneumonia. Hence, the medical specialists can identify the COVİD-19 infection in the initial stage.
For investigations regarding the identification of COVID-19, four dissimilar datasets were designed by
considering patches with dimensions as 64 × 64, 48 × 48, 32 × 32 and 16 × 16 from a number of 150 CT
scans. To improve the classification performance, a feature extraction process was applied to patches,
which utilized algorithms such as Grey Level Co-occurrence Matrix (GLCM), Local Directional Pattern
(LDP), Grey Level Run Length Matrix (GLRLM), Grey-Level Size Zone Matrix (GLSZM), and Discrete
Wavelet Transform (DWT). Support Vector Machines (SVM) were used to categorize the extracted
features. Ten-fold, 5-fold, and 2-fold cross-validations were applied throughout the categorization
process. Precision, accuracy, specificity, sensitivity, and F-score metrics were utilized to assess the
categorization performance. The best accuracies were achieved as 99.68% with 10-fold cross-validation
and the GLSZM feature extraction technique.
It is obvious that an initial identification of COVID-19 is essential to slow down the spread of
COVID-19 and avoid transmission by an early quarantine of victims as well as tracing and isolation
of close acquaintances. For patients diagnosed with COVID-19, the precise monitoring of disease
development is a vital element of disease administration. Medical imaging records such as chest X-ray
and CT scans play a significant part in confirming the positive identification of COVID-19 disease as
well as observing the evolution of the disease. These sorts of imaging data exhibit irregular distinctive
patterns that emerge right after the COVID-19 infection starts. These anomalies peaked during 6th to
11th day of the illness. The next most predominant pattern of lung conditions anomalies peaks during
the 12th to 17th day of the illness [16]. Computer-Aided Diagnosis (CAD) methods that integrate
X-ray and CT scan results with deep learning algorithms can help physicians as identification aids for
COVID-19 and assist further to provide a better understanding of the disease progression.
can also be applied to prevent the exposure of medical professionals to the high-risk patient populations.
IoT 2020, 1, FOR PEER REVIEW 7
In principle, the same technological arrangements presently utilized by remote monitoring programs
can alsopersons
be utilizedexposed to COVID-19a temperature
to incorporate as well as close acquaintances
measurement of such
tool the infected person.
as a smart These
thermometer for
technologies
monitoring individualscan also
thatbeare
applied to prevent
suspected the exposure
of having of medical
COVID-19 [7]. professionals
AI and ML can to the high-risk
significantly help
patient populations. In principle, the same technological arrangements presently utilized by remote
to improve monitoring and identify abnormal patterns or behaviors. ML and AI-based advanced data
monitoring programs can also be utilized to incorporate a temperature measurement tool such as a
analyticssmart
andthermometer
signal processing can help to filter the data and identify the patterns.
for monitoring individuals that are suspected of having COVID-19 [7]. AI and
ML can significantly help to improve monitoring and identify abnormal patterns or behaviors. ML
2.3. Drug Development,
and Selection
AI-based advanced dataand Delivery
analytics and signal processing can help to filter the data and identify
In the
[17],patterns.
the authors use a drug–target interaction prototype titled as Molecule Transformer–
DrugTarget Interaction
2.3. Drug Development,(MT-DTI) that
Selectio,n anduses the deep learning method to identify drugs that are available
Delivery
in the market to react on viral proteins of SARS-COV-2. In another paper [18], the authors formulated
In [17], the authors use a drug–target interaction prototype titled as Molecule Transformer–
a modelDrugTarget
that uses machine learning technology to forecast the potential inhibitory synthetic antibodies
Interaction (MT-DTI) that uses the deep learning method to identify drugs that are
for SARS-COV-2
available in the market togathered
virus. They antibody
react on viral proteinssequences of theIn1933
of SARS-COV-2. virus
another and[18],
paper their
theclinical
authors patient
formulated a model that uses machine learning technology to forecast the potential inhibitoryreaction.
neutralization reaction and pre-trained a machine learning model to forecast the antibody
Utilizingsynthetic
graphicalantibodies for SARS-COV-2
representation withvirus. They gathered
different antibody sequences
ML techniques, of the 1933
the authors virus and
selected thousands
their clinical patient neutralization reaction and pre-trained a machine learning
of antibody sequences and found eight steady antibodies that hypothetically inhibit SARS-COV-2. model to forecast the
antibody reaction. Utilizing graphical representation with different ML techniques, the authors
The authors combined bioinformatics, structural biology, and Molecular Dynamics (MD) simulations
selected thousands of antibody sequences and found eight steady antibodies that hypothetically
to authenticate the constancy
inhibit SARS-COV-2. Theofauthors
the candidate
combined antibodies that can
bioinformatics, inhibitbiology,
structural the SARS-COV-2
and Molecular virus.
Dynamics (MD) simulations to authenticate the constancy of the candidate antibodies that can inhibit and it
Nowadays, we are observing rapid advancement in every aspect of science and technology,
thesame
is also the SARS-COV-2
scenario virus.
in the sector of biological science, where complex biological data such as DNA
structures and Nowadays,
proteinwe are observing
sequences arerapid
nowadvancement in every
available. With theaspect
helpofof science and technology,
machine and
learning techniques,
it is also the same scenario in the sector of biological science, where complex biological data such as
those available data can predict complex biological scenario to analyze the virus protein structure and
DNA structures and protein sequences are now available. With the help of machine learning
potentialtechniques,
antibodies. With proper and sufficient training data, a machine learning mechanism can be
those available data can predict complex biological scenario to analyze the virus protein
utilized structure
to createand relations between
potential the virus
antibodies. entity and
With proper and reaction
sufficient of its probable
training data, a antibody. A pre-trained
machine learning
ML toolmechanism
can predict can be utilized
potential to create relations
antibodies between
for a given the virus
protein entity of
sequence anda reaction of its than
virus faster probable
the human
immuneantibody.
system,Awhichpre-trained
can be ML tool useful
very can predict
whilepotential
combating antibodies for aany
against given protein sequence
pandemic such asofCOVID-19
a
and canvirus
savefaster
many than the in
lives human immune
a timely system, which can be very useful while combating against any
manner.
pandemic such as COVID-19 and can save many lives in a timely manner.
According to another study [4], in China, one approach that was utilized to overcome the medicine
According to another study [4], in China, one approach that was utilized to overcome the
deliverymedicine
concerns during
delivery the epidemic
concerns during thewas by employing
epidemic an IoT-based
was by employing service
an IoT-based platform
service platform(Figure 3
exhibits(Figure 3 exhibits the workflow). The platform created orders by automatically analyzing the
the workflow). The platform created orders by automatically analyzing the information from
information
historical records. from
Those historical
ordersrecords.
may be Those orders may
modified and be modified and
submitted by submitted by the pharmacists
the pharmacists and then sent to
and then
the medicine sent to thefrom
suppliers medicine
where suppliers from whereare
the medicines thedistributed
medicines arewithin
distributed within a specified
a specified time. This had
time. This had lessened the spread of the disease during medicine purchase and also saved resources
lessened the spread of the disease during medicine purchase and also saved resources and labor cost.
and labor cost.
(3) Automatically
IoT based service (1) Input data of
generated and placed
platform for previous sales
order based on forecast
drug delivery
(7) Acceptance of
product at warehouse/
(6) Delivery of products
drugstore/ hospital
electronic inventory
pandemic-related information in a timely and precise way is tremendously vital for the anti-epidemic
reaction of the community. The transparency in information sharing could have minimized the spread
of this disease at the initial phase of the pandemic. Another reason is the unavailability of a proper
systematic diagnosis standard for this virus. The prompt development of testing systems for a novel
virus is very challenging. The symptoms of this virus are highly alike to symptoms of other less
dangerous flu, which worsens the accuracy of diagnosis. Finally, due to the absence of a proper
epidemic warning and prediction arrangement, we lost the chance to prohibit the spreading of this
disease at the early phase.
In the current SARS-COV-2 transmission situation, the epidemiological study is tremendously
essential for preventing the transmission by tracing the contagious trails and detecting the connection
chains contributing to the rapid spreading. However, the outbreak of the COVID-19 was boosted
up by the high movement of people during the most significant customary carnival of China,
which worsened the transmission of the virus and at the same time greatly amplified the challenges of
the epidemiological investigation [19]. It is vital to observe and predict the evolution of an epidemic
while making decision against this kind of health crisis. In this situation, the mathematical propagation
model has achieved more consideration and attention in terms of the epidemiological research.
The Susceptible–Infected–Removed (SIR) model is one of those mathematical propagation models.
The research on plague in the early 20th century introduced this SIR model. Remarkable development
has been made in the mathematical propagation model of epidemiological research since the middle
of the 20th century. At present, some important factors inducing the epidemic transmission were
incorporated in the classic SIR model, such as the model taking into consideration the maturation phase,
the SEIRS (Susceptible–Exposed–Infectious–Recovered–Susceptible) model taking into consideration
the age of people and the population exposed to an epidemic and the Susceptible–Infectious–Susceptible
(SIS) model including the birth and death of vulnerable patients. Some dynamical prototypes
were planned to consider only specific disease analysis. For instance, the dynamical models were
designed to simulate the spreading of human immunodeficiency virus (HIV), severe acute respiratory
syndrome (SARS), and Middle East Respiratory Syndrome (MERS). With the advancement of innovative
techniques, complex network theories and machine learning techniques were incorporated with the
mathematical propagation model, which generated an effective method of epidemic prediction.
The construction of the SIR prototype for an epidemic analysis requires defining a number
of vital parameters (such as the rate of infection and the rate of infection elimination) factually or
statistically. The SIR prototype has established a complex model enabling a more detailed classification
of individuals—for example, the exposed group and the protection group. As a matter of fact, the more
accurate the prototype, the more chances are there that it can make an accurate forecast. However,
for better accuracy, the model requires more realistic data to define additional factors. Alternately,
some effort has also been made for developing a simplified prototype. For instance, the renowned
logistic equation was used as the two sections “S-I” (Susceptible–Infectious) prototype, which can
be additionally incorporated for some procedures in the modeling of SARS. The aforementioned
studies demonstrate that the SIR-family prototypes can capture the base mechanism of the epidemic
transmission at diverse complex stages quite well.
In one study [19], the authors tried to represent an initial forecast of the COVID-19 epidemic
obtained from a basic SIR prototype. The justification of the obtained epidemiological information was
investigated initially to achieve a realistic approximation of the fundamental factor, such as the rate
of infection. Focusing on the rate of infection and the rate of disease elimination, a number of trials
were planned to simulate the transmission of SARS-COV-2 virus under diverse stages of anti-epidemic
measure and precautions. The forecasted infection intervals for the collective cases and the fading-out
time of the epidemic are presented. The outcomes of the study are supposed to deliver vital statistics
for crisis management against this COVID-19 pandemic.
IoT 2020, 1 514
important. They are not only helping to collect the COVID data but also helping the vulnerable
patients
IoT 2020, in
1 person, risking their own life. AI and ML can help identify the risk and also help automate 515
a number of functionalities. Reflecting on a swiftly rising fear in the present epidemic that concerns
the contamination of medical staff, Kuan Chen, founder of Infervision, points out that the AI
Reflecting on
application a swiftly
can assist rising fear in the
in protecting present
the epidemic
healthcare that concerns
professionals the Similarly,
[26]. contamination of medical
researchers and
staff, Kuan Chen, founder of Infervision, points out that the AI application can assist in
vendors are trying to utilize AI-enabled medical devices to reduce direct contact during SARS-COV-protecting
2 the healthcare professionals [26]. Similarly, researchers and vendors are trying to utilize AI-enabled
virus diagnosis and treatment.
medical devices to reduce direct contact during SARS-COV-2 virus diagnosis and treatment.
2.7. AI-Enabled Self-Testing Framework
2.7. AI-Enabled Self-Testing Framework
An
AnAI-enabled self-testingframework
AI-enabled self-testing framework is shown
is shown in Figure
in Figure 4. The4.framework
The framework
has threehas three
major major
phases.
phases. At the initial phase, the patient-side sensor devices will collect the specimen supplied
At the initial phase, the patient-side sensor devices will collect the specimen supplied by the patient. by the
patient.
Based onBased on the samples
the samples collectedcollected by the sensors,
by the sensors, AI and ML-based
AI and ML-based analytics analytics willfor
will be used be further
used for
further processing. Decisions can be made locally in an edge node or could be
processing. Decisions can be made locally in an edge node or could be in the cloud when compared in the cloud when
compared with data
with historical historical data if necessary.
if necessary. Finally,
Finally, based on thebased on the patients
test results, test results,
willpatients willvia
be notified bemobile
notified
via mobile phone. To communicate among the peers, the blockchain-based framework
phone. To communicate among the peers, the blockchain-based framework could be very helpful. could be very
helpful. As results
As the test the test
areresults are very
very sensitive sensitive
and and require
require better security better security
and privacy and privacy
protection, protection,
blockchain may
blockchain may serve
serve that purpose. thatapurpose.
Being Being
distributed ledgera distributed
technology, ledger technology, the
the blockchain-based blockchain-based
framework can be
framework can be
connected with connected
local with local
and international and international
databases, databases,
while the AI-based while the AI-based
decision-making process decision-
helps
making
patientsprocess helps patients
with self-diagnosis with self-diagnosis [27].
[27].
Table
Table11 summarizes
summarizes the
the articles and projects
articles and projects related
related to
tothe
theAI
AIapplications
applicationstoward
towardimproved
improved
resiliency against the COVID-19 pandemic.
resiliency against the COVID-19 pandemic.
IoT 2020, 1 516
Table 1. Cont.
demonstrate a novel hybrid machine learning prototype, SIRNET (named after the foundational
epidemiological model SIR), for predicting the transmission of the COVID-19 epidemic that combines
with the epidemiological prototypes. The authors utilized the characterization of spatiotemporal
cell-phone movement information, along with population density and other local data points.
In that work, trial outcomes from SIRNET are considered to create initial boundaries on such
localized movement that enable disease containment over time. The prototype can support studying
non-pharmacological mitigation techniques that minimize corresponding cases and develop control
mechanisms for a prolonged period of time.
SIRNET is a hybrid between machine learning methods, physical science, and epidemic modeling.
The epidemic modeling generates significant variables from a physical perspective that adds a
spontaneous understanding of how the prototype can be used for forecasting disease trends. In addition,
machine learning methods offer an instrument for interpreting variables—for example, movement,
non-pharmacological mitigation techniques, and population demographics—into variables that
influence a pandemic prototype. It also allows us to determine connections between real-world trends
on the spread of COVID-19, as well as the influence of underlying scenarios such as relaxing social
distancing rules.
3.5. AI Governance
The wide adoption of AI has impacted our socio-economic life, and therefore, it has a significant
influence on government policy and decision making. In this regard, article [32] described the
detailed effects of computerized decision support mechanisms on community services and the
growing potentials for administrations to become an indispensable part of the digital community.
The government authorities can compare the suitability of the prospective technologies while controlling
and perhaps avoiding undesirable effects. This is highly important in the present situation of the
COVID-19 epidemic where artificial intelligence and the supporting governing structure of the
information network have become strategic concerns, as a large number of inventions are based on big
data acquisition from smart appliances and the real-time availability of data and services.
The utilization of computerized decision-making systems in the public sector has certain values
and requirements that it offers to deliver. This type of computerized system is important in the current
situation of the COVID-19 pandemic, as the authorities are developing applications or tools that can
monitor human mobility in an effort to reduce the probabilities of spreading.
For most of the artificial intelligence-based applications used in the public sector, the goal is
to increase the efficiency and value of services, which is not completely addressed in the case of
many other technology-agnostic services of the public sector. Moreover, it is beneficial to measure the
appropriateness of the existing performance measurement tools and determine the way they can be
further developed in the future, particularly if the condition after crisis does not bring us to “normality”
IoT 2020, 1 519
and rather forces us collectively to alter our lifestyles and brings challenges to our regular social life
and if the preventive actions are necessary to anticipate new challenges.
Table 2. Summary of the research contributions considering AI for social science applications.
Table 2. Cont.
tokens received by his/her phone, which the government can decrypt and relate with phone numbers
and identities [41].
Decentralized Privacy-Preserving Proximity Tracing (DP3T): This decentralized solution is
proposed by the Pan-European Privacy-Preserving Proximity Tracing project team [43], which prompts
individual users to generate daily random keys and broadcast ephemeral identifiers in random order.
The users store all identifiers along with their proximities in the device database. If a user is detected
as COVID-positive, the central health authority will request the user’s secret key for the first day
when the user became infected. Then, the secret key is then broadcast to all users, who can compute
ephemeral identifiers for that specific day and subsequent days. As a result, other users can check if
they were in close proximity of the user tested as COVID-19 positive for the past few days [42].
Efficient Privacy-Preserving Contact Tracing (EPIC): In this solution, the user devices exchange
Bluetooth messages with nearby user devices and the server [44]. When the server has information on
the infected users, it offers data-matching services only to users who are interested to know if they
have shared the same location with the infected person. For this, the interested user sends timestamp
messages to the server using homomorphic encryption, and the server reports back with the overlapped
timestamps from the infected user. Then, the interested user sends the matched timestamps to the
server, which computes the distance between the interested user and user infected with COVID-19 and
forwards the information [42].
Contact Categorization: The solution utilizes contact categories rather than locations for infection
spread detection. The user devices store a list of contacts based on the received Bluetooth messages.
The developed application matches this list with the list of people infected with the virus, as obtained
from the health authority. When a match is found, the application categorizes the contact based on the
duration for which the non-infected user has been in contact with the user infected with COVID-19.
The categorization helps the health authority prioritize testing when the infection spreading level is
very high. Based on the signal strength, the proximity of the infected and non-infected users can also
be obtained similar to the other approaches [45].
Privacy-Sensitive Protocols and Mechanisms for Mobile Contact Tracing (PACT): The solution
enables users to generate pseudorandom IDs and broadcast to nearby users. Each user stores the
received ID and time stamp. The users infected with COVID-19 upload the IDs and time stamps to the
server, and the server adds the information to the list of users tested as COVID-positive. Any user can
download this list and extract the IDs as well as time stamps to match with its local storage and find
out if the user is in close proximity of the user infected with COVID-19. The solution allows for a time
delay before the ID, and time stamps are added to the public list to prevent replay attacks. In addition,
it uses a predetermined schedule of updating seeds for a pseudorandom generator [40].
Vici InTouch) can be used for the remote monitoring of patients in quarantine without the physical
presence of the health workers. A number of hospitals in the USA monitor patients in intensive care
units through the use of bidirectional audio and video communications [51].
Table 3. Cont.
6. Conclusions
In this paper, a range of medical sector applications such as drug delivery and infection detection
based on AI and ML techniques have been elaborated. Moreover, AI and ML applications for
forecasting disease trends and developing social awareness programs have been outlined. In addition,
the recent advancements in IoT for tracing and reporting patients infected with COVID-19, as well
as the potential applications in automated monitoring through wearables technologies have been
reviewed. The applications of blockchain technologies for decentralized decision making in healthcare
systems during COVID-19 scenarios have been outlined. Security and privacy aspects of the AI, ML,
and IoT technologies have also been elaborated, along with their impact on the critical policy-making
IoT 2020, 1 525
operations. Future studies will be performed to extend the findings for developing new algorithms for
IoT-aided COVID-19 health-monitoring applications.
Author Contributions: Conceptualization, A.A. and A.M.T.O.; methodology, S.N.I.; software, A.N.M.; validation,
S.M.A.A.A., and S.N.I.; formal analysis, S.M.A.A.A.; investigation, A.A. and A.N.M.; resources, A.M.T.O.;
data curation, S.M.A.A.A; writing—original draft preparation, S.M.A.A.A. and S.N.I.; writing—review and editing,
A.A.; visualization, A.A.A. and S.N.I.; supervision, A.N.M.; project administration, A.M.T.O.; All authors have
read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Timeline: WHO’s COVID-19 Response. Available online: https://www.who.int/emergencies/diseases/novel-
coronavirus-2019/interactive-timeline?gclid=CjwKCAiA2O39BRBjEiwApB2Ikh-fQFKjiYNKczrHGfW-
VpPVYkuNEh6d53pNhA8fEM1WYjtAfpaSERoC0lkQAvD_BwE#event-115 (accessed on 24 August 2020).
2. WHO Coronavirus Disease (COVID-19) Dashboard. Available online: https://covid19.who.int/ (accessed on
24 August 2020).
3. COVID-19 Coronavirus Pandemic, Worldometer. Available online: https://www.worldometers.info/
coronavirus/ (accessed on 24 August 2020).
4. Elavarasan, R.M.; Pugazhendhi, R. Restructured society and environment: A review on potential technological
strategies to control the COVID-19 pandemic. Sci. Total Environ. 2020, 725, 138858. [CrossRef]
5. Bullock, J.; Luccioni, A.; Hoffmann Pham, K.; Lam, C.S.N.; Luengo-Oroz, M. Mapping the landscape of
Artificial Intelligence applications against COVID-19. arXiv 2020, arXiv:2003.11336.
6. COVID-19 Open Research Dataset (CORD-19). Semantic Scholar. Published 2020. Available online:
https://pages.semanticscholar.org/coronavirus-research (accessed on 30 March 2020).
7. Alwashmi, M.F. The Use of Digital Health in the Detection and Management of COVID-19. Int. J. Environ.
Res. Public Health 2020, 17, 2906. [CrossRef]
8. One Healthcare Cloud: Many Imaging Solutions, Cimar. Available online: www.cimar.co.uk (accessed on
25 November 2020).
9. Hare, S.; Rodrigues, J.; Jacob, J.; Edey, A.; Devaraj, A.; Johnstone, A.; McStay, R.; Nair, A.; Robinson, G.
A UK-wide British Society of Thoracic Imaging COVID-19 imaging repository and database: Design, rationale
and implications for education and research. Clin. Radiol. 2020, 75, 326–328. [CrossRef]
10. Shobha, G.; Rangaswamy, S. Chapter 8—Machine Learning. In Handbook of Statistics; Elsevier: Amsterdam,
The Netherlands, 2018; Volume 38, pp. 197–228.
11. Bogoch, I.I.; Watts, A.; Thomas-Bachli, A.; Huber, C.; Kraemer, M.U.G.; Khan, K. Pneumonia of unknown
aetiology in Wuhan, China: Potential for international spread via commercial air travel. J. Travel Med. 2020,
27, 1–3. [CrossRef]
12. Shi, F.; Wang, J.; Shi, J.; Wu, Z.; Wang, Q.; Tang, Z.; He, K.; Shi, Y.; Shen, D. Review of Artificial Intelligence
Techniques in Imaging Data Acquisition, Segmentation and Diagnosis for COVID-19. IEEE Rev. Biomed. Eng.
2020, 1. [CrossRef]
13. Meng, L. Review: Chest CT Features and Their Role in COVID-19. Radiology of Infectious Diseases.
Available online: www.sciencedirect.com (accessed on 30 March 2020).
14. Loey, M.; Smarandache, F.M.; Khalifa, N.E. Within the Lack of Chest COVID-19 X-ray Dataset: A Novel
Detection Model Based on GAN and Deep Transfer Learning. Symmetry 2020, 12, 651. [CrossRef]
15. Öztürk, Ş.; Özkaya, U.; Barstuğan, M. Classification of Coronavirus (COVID-19) from X-ray and CT images
using shrunken features. Int. J. Imaging Syst. Technol. 2020. [CrossRef] [PubMed]
16. Kassania, S.H.; Kassasnib, P.H.; Wesolowskic, M.J.; Schneider, K.A.; Deters, R. Automatic Detection of
Coronavirus Disease (COVID-19) in X-ray and CT Images: A Machine Learning Based Approach. arXiv
2020, arXiv:2004.10641.
17. Beck, B.R.; Shin, B.; Choi, Y.; Park, S.; Kang, K. Predicting commercially available antiviral drugs that
may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model.
Comput. Struct. Biotechnol. J. 2020, 18, 784–790. [CrossRef] [PubMed]
IoT 2020, 1 526
18. Magar, R.; Yadav, P.; Farimani, A.B. Potential Neutralizing Antibodies Discovered for Novel Corona Virus
Using Machine Learning. arXiv 2020, arXiv:2003.08447.
19. Zhong, L.; Mu, L.; Li, J.; Wang, J.; Yin, Z.; Liu, D. Early Prediction of the 2019 Novel Coronavirus Outbreak in
the Mainland China Based on Simple Mathematical Model. IEEE Access 2020, 8, 51761–51769. [CrossRef]
[PubMed]
20. Vaishya, R.; Javaid, M.; Khan, I.H.; Haleem, A. Artificial Intelligence (AI) applications for COVID-19
pandemic. Diabetes Metab. Syndr. Clin. Res. Rev. 2020, 14, 337–339. [CrossRef] [PubMed]
21. Magdon-Ismail, M. Machine Learning the Phenomenology of COVID-19 From Early Infection Dynamics.
arXiv 2020, arXiv:2003.07602.
22. Ghoshal, B.; Tucker, A. Estimating Uncertainty and Interpretability in Deep Learning for Coronavirus
(COVID-19) Detection. arXiv 2020, arXiv:2003.10769v3.
23. Ndiaye, B.M.; Tendeng, L.; Seck, D. Analysis of the COVID-19 pandemic by SIR model and machine learning
technics for forecasting. arXiv 2020, arXiv:2004.01574v1.
24. Batra, R.; Chan, H.; Kamath, G.; Ramprasad, R.; Cherukara, M.J.; Sankaranarayanan, S. Screening of
Therapeutic Agents for COVID-19 using Machine Learning and Ensemble Docking Simulations. arXiv 2020,
arXiv:2004.03766v1.
25. Magri, L.; Khoa Doan, N.A. First-principles machine learning modelling of COVID-19. arXiv 2020,
arXiv:2004.09478v1.
26. McCall, B. COVID-19 and artificial intelligence: Protecting health-care workers and curbing the spread.
Lancet Digit. Health 2020, 2, e166–e167. [CrossRef]
27. Mashamba-Thompson, T.P.; Crayton, E.D. Blockchain and Artificial Intelligence Technology for Novel
Coronavirus Disease 2019 Self-Testing. Diagnostics 2020, 10, 198. [CrossRef]
28. Liu, D.; Clemente, L.; Poirier, C.; Ding, X.; Chinazzi, M.; Davis, J.T.; Vespignani, A.; Santillana, M. A machine
learning methodology for real-time forecasting of the 2019–2020 COVID-19 outbreak using Internet searches,
news alerts, and estimates from mechanistic models. arXiv 2020, arXiv:2004.04019v1.
29. Qi, X.; Mei, G.; Cuomo, S.; Xiao, L. A network-based method with privacy-preserving for identifying
influential providers in large healthcare service systems. Futur. Gener. Comput. Syst. 2020, 109, 293–305.
[CrossRef] [PubMed]
30. Soures, N.; Chambers, D.; Carmichael, Z.; Daram, A.; Shah, D.P.; Clark, K.; Potter, L.; Kudithipudi, D.
SIRNET: Understanding Social Distancing Measures with Hybrid Neural Network Model for COVID-19
Infectious Spread. arXiv 2020, arXiv:2004.10376v1.
31. Li, L.; Zhang, Q.; Wang, X.; Zhang, J.J.; Wang, T.; Gao, T.-L.; Duan, W.; Tsoi, K.K.-F.; Wang, F.-Y.
Characterizing the Propagation of Situational Information in Social Media During COVID-19 Epidemic:
A Case Study on Weibo. IEEE Trans. Comput. Soc. Syst. 2020, 7, 556–562. [CrossRef]
32. Kuziemski, M.; Misuraca, G. AI governance in the public sector: Three tales from the frontiers of automated
decision-making in democratic settings. Telecommun. Policy 2020, 44, 101976. [CrossRef]
33. Pandey, R.; Gautam, V.; Jain, C.; Syal, P.; Sharma, H.; Bhagat, K.; Pal, R.; Dhingra, L.S.; Arushi; Patel, L.;
et al. A Machine Learning Application for Raising WASH Awareness in the Times of COVID-19 Pandemic.
arXiv 2020, arXiv:2003.07074.
34. Rashid, M.T.; Wang, D. CovidSens: A Vision on Reliable Social Sensing based Risk Alerting Systems for
COVID-19 Spread. arXiv 2020, arXiv:2004.04565v1.
35. Bell, J.; Butler, D.; Hicks, C.; Crowcroft, J. TraceSecure: Towards Privacy Preserving Contact Tracing.
arXiv 2020, arXiv:2004.04059v1.
36. Roomp, K.; Oliver, N. ACDC-Tracing: Towards Anonymous Citizen-Driven Contact Tracing. arXiv 2020,
arXiv:2004.07463.
37. Lorch, L.; Trouleau, W.; Tsirtsis, S.; Szanto, A.; Schölkopf, B.; Gomez-Rodriguez, M. A Spatiotemporal
Epidemic Model to Quantify the Effects of Contact Tracing, Testing, and Containment. arXiv 2020,
arXiv:2004.07641v1.
38. Venkateswaran, J.; Damani, O. Effectiveness of Testing, Tracing, Social Distancing and Hygiene in Tackling
Covid-19 in India: A System Dynamics Model. arXiv 2020, arXiv:2004.08859.
39. Kim, H.; Paul, A. Contact Tracing: A game of big numbers in the time of COVID-19. arXiv 2020,
arXiv:2004.10762v1. [CrossRef]
IoT 2020, 1 527
40. Chan, J.; Foster, D.; Gollakota, S.; Horvitz, E.; Jaeger, J.; Kakade, S.; Kohno, T.; Langford, J.; Larson, J.;
Singanamalla, S.; et al. PACT:Privacy-Sensitive Protocols And Mechanisms for Mobile Contact Tracing.
arXiv 2020, arXiv:2004.03544v3.
41. Cho, H.; Ippolito, D.; Yu, Y.W. Contact Tracing Mobile Apps for COVID-19:Privacy Considerations and
Related Trade-offs. arXiv 2020, arXiv:2003.11511v2.
42. Tang, Q. Privacy-Preserving Contact Tracing: Current solutions and open questions. arXiv 2020,
arXiv:2004.06818v2.
43. Troncoso, C.; Payer, M.; Hubaux, J.-P.; Salathé, M.; Larus, J.; Bugnion, E.; Lueks, W.; Stadler, T.; Pyrgelis, A.;
Antonioli, D.; et al. Decentralized Privacy-Preserving Proximity Tracing. arXiv 2020, arXiv:2005.12273.
44. Altuwaiyan, T.; Hadian, M.; Liang, X. EPIC: Efficient Privacy-Preserving Contact Tracing for Infection
Detection. In Proceedings of the 2018 IEEE International Conference on Communications (ICC), Kansas City,
MO, USA, 24–28 May 2018.
45. Michael, C.; Günther, D. Tracing Contactsto Control the COVID-19 Pandemic. arXiv 2020, arXiv:2004.00517v1.
46. Rahman, S.; Peeri, N.C.; Shrestha, N.; Zaki, R.; Haque, U.; Ab Hamid, S.H. Defending against the
Novel Coronavirus (COVID-19) outbreak: How can the Internet of Things (IoT) help to save the world?
Health Policy Technol. 2020, 9, 136–138. [CrossRef]
47. Bai, L.; Yang, D.; Wang, X.; Tong, L.; Zhu, X.; Zhong, N.; Bai, C.; Powell, C.A.; Chen, R.; Zhou, J.; et al.
Chinese experts’ consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease
2019 (COVID-19). Clin. eHealth 2020, 3, 7–15. [CrossRef]
48. Montag, C.; Becker, B.; Gan, C. The Multipurpose Application WeChat: A Review on Recent Research.
Front. Psychol. 2018, 9, 2247. [CrossRef]
49. Yang, T.; Gentile, M.; Shen, C.-F.; Cheng, C. Combining Point-of-Care Diagnostics and Internet of Medical
Things (IoMT) to Combat the COVID-19 Pandemic. Diagnostics 2020, 10, 224. [CrossRef] [PubMed]
50. Torous, J.; Keshavan, M. COVID-19, mobile health and serious mental illness. Schizophr. Res. 2020, 218, 36–37.
[CrossRef] [PubMed]
51. Kapoor, A.; Guha, S.; Das, M.; Goswami, K.C.; Yadav, R. Digital healthcare: The only solution for better
healthcare during COVID-19 pandemic? Indian Hear. J. 2020, 72, 61–64. [CrossRef] [PubMed]
52. Ying, W.; Qian, Y.; Kun, Z. Drugs supply and pharmaceutical care management practices at a designated
hospital during the COVID-19 epidemic. Res. Soc. Adm. Pharm. 2020. [CrossRef] [PubMed]
53. Gupta, M.; Abdelsalam, M.; Mittal, S. Enabling and Enforcing Social Distancing Measures using Smart City
and ITS Infrastructures:A COVID-19 Use Case. arXiv 2020, arXiv:2004.09246v1.
54. Saraereh, O.A.; Alsaraira, A.; Khan, I.; Uthansakul, P. Performance Evaluation of UAV-Enabled LoRa
Networks for Disaster Management Applications. Sensors 2020, 20, 2396. [CrossRef] [PubMed]
55. Kellermann, R.; Biehle, T.; Fischer, L. Drones for parcel and passenger transportation: A literature review.
Transp. Res. Interdiscip. Perspect. 2020, 4. [CrossRef]
56. Mesar, T.; Lessig, A.; King, D.R. Use of Drone Technology for Delivery of Medical Supplies During Prolonged
Field Care. J. Spéc. Oper. Med. 2018, 18, 34–35.
57. Chu, L.C.; Anandkumar, A.; Shin, H.C.; Fishman, E.K. The Potential Dangers of Artificial Intelligence for
Radiology and Radiologists. J. Am. Coll. Radiol. 2020, 17, 1309–1311. [CrossRef]
58. Mirsky, Y.; Mahler, T.; Shelef, I.; Elovici, Y. CT-GAN: Malicious Tampering of 3D Medical Imagery using Deep
Learning. In Proceedings of the 28th USENIX Security Symposium, Santa Clara, CA, USA, 14–16 August 2019;
pp. 461–478.
59. Vaudenay, S. Analysis of DP3T Between Scylla and Charybdis. Available online: https://infoscience.epfl.ch/
record/277808/files/dp3t-ana.pdf (accessed on 10 July 2020).
60. Seh, A.H.; Zarour, M.; Alenezi, M.; Sarkar, A.K.; Alenezi, M.; Kumar, R.; Agrawal, A. Healthcare Data
Breaches: Insights and Implications. Healthcare 2020, 8, 133. [CrossRef]
61. Wang, S.; Bolling, K.; Mao, W.; Reichstadt, J.; Jeste, D.; Kim, H.-C.; Nebeker, C. Technology to Support Aging
in Place: Older Adults’ Perspectives. Healthcare 2019, 7, 60. [CrossRef] [PubMed]
62. Van den Hooff, J.; Lazar, D.; Zaharia, M.; Zeldovich, N. Vuvuzela: Scalable private messaging resistant to
traffic analysis. In Proceedings of the 25th Symposium on Operating Systems Principles (SOSP ‘15); Association for
Computing Machinery: New York, NY, USA, 2015; pp. 137–152.
63. Freedman, M.J.; Nissim, K.; Pinkas, B. Efficient Private Matching and Set Intersection. Lecture Notes
Comput. Sci. 2004, 1–19. [CrossRef]
IoT 2020, 1 528
64. Allam, Z.; Jones, D.S. On the Coronavirus (COVID-19) Outbreak and the Smart City Network: Universal Data
Sharing Standards Coupled with Artificial Intelligence (AI) to Benefit Urban Health Monitoring and
Management. Healthcare 2020, 8, 46. [CrossRef] [PubMed]
65. Wheelus, C.; Zhu, X. IoT Network Security: Threats, Risks, and a Data-Driven Defense Framework. IoT 2020,
1, 259–285. [CrossRef]
66. Liu, H.; Crespo, R.G.; Martínez, O.S. Enhancing Privacy and Data Security across Healthcare Applications
Using Blockchain and Distributed Ledger Concepts. Healthcare 2020, 8, 243. [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional
affiliations.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).